Monday, May 15, 2023

Scoop: PharmEasy valuation halved to $2.8 billion, logs Ebitda profitability; Paytm’s loan biz decoded

Online pharmacy PharmEasy recorded a positive Ebitda of around Rs 14 crore, which means it is operationally profitable, even as one of its investors marked its valuation down to $2.8 billion. This and more in today’s ETtech Morning Dispatch.

from Tech-Economic Times https://ift.tt/w8yPXgO
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Zetwerk IPO: Size, valuation, timeline and other details we know so far

Zetwerk is preparing to confidentially file IPO papers to raise up to $550 million at a $4 billion valuation, including fresh equity and OFS...